Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NYSTATIN vs OCRIPLASMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NYSTATIN vs OCRIPLASMIN: Safety Overview

Metric NYSTATIN OCRIPLASMIN
Total FAERS Reports 1,892 306
Deaths Reported 179 2
Death Rate 9.5% 0.7%
Hospitalizations 457 7
Average Patient Age 55.9 yrs 65.7 yrs
% Female Patients 67.2% 73.1%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Crown Laboratories N/A
Route TOPICAL N/A
Marketing Status Discontinued Prescription